IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.058
EU - Europa 6.772
AS - Asia 3.564
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 15
SA - Sud America 6
OC - Oceania 3
Totale 18.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.844
CN - Cina 2.670
UA - Ucraina 1.468
IE - Irlanda 1.299
DE - Germania 1.014
FI - Finlandia 910
SE - Svezia 875
IT - Italia 827
SG - Singapore 679
CA - Canada 210
TR - Turchia 164
AT - Austria 127
GB - Regno Unito 86
FR - Francia 49
BE - Belgio 38
EU - Europa 19
IN - India 17
RO - Romania 17
ES - Italia 13
NL - Olanda 13
JP - Giappone 12
CZ - Repubblica Ceca 11
BR - Brasile 5
CI - Costa d'Avorio 5
ID - Indonesia 4
IL - Israele 4
EE - Estonia 3
EG - Egitto 3
HK - Hong Kong 3
IR - Iran 3
MX - Messico 3
NZ - Nuova Zelanda 3
PL - Polonia 3
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CH - Svizzera 2
HU - Ungheria 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
GR - Grecia 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RW - Ruanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 18.437
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.542
Dublin 1.297
Chandler 1.006
Dearborn 762
Beijing 743
Nanjing 483
Singapore 481
Ashburn 478
Boardman 472
Princeton 365
Ann Arbor 286
San Mateo 285
Wilmington 206
Toronto 194
Kunming 169
Bremen 167
Parma 158
Shenyang 154
Izmir 150
Hefei 149
Nanchang 138
Vienna 126
Hebei 118
New York 116
Des Moines 100
Shanghai 99
Jinan 88
Helsinki 71
Grafing 68
Jiaxing 62
Santa Clara 60
Tianjin 54
Woodbridge 51
Changsha 49
Guangzhou 47
Norwalk 47
Seattle 44
Düsseldorf 37
Brussels 36
Fremont 34
Marseille 32
Hangzhou 28
Rome 28
Zhengzhou 27
Chengdu 24
Los Angeles 21
Fuzhou 19
Milan 19
Ningbo 17
Houston 16
Dallas 15
Haikou 13
Reggio Nell'emilia 13
Torino 13
Kocaeli 12
Modena 12
Taiyuan 12
Taizhou 12
Wenzhou 12
Wuhan 12
Nakano 11
Shaoxing 11
Auburn Hills 10
Florence 10
Redmond 10
Timisoara 10
Washington 10
Falls Church 9
Munich 9
Napoli 9
Redwood City 9
Verona 9
Palermo 8
Rockville 8
Borås 7
Catania 7
Chongqing 7
Xian 7
Bari 6
Bilbao 6
Bologna 6
Frankfurt am Main 6
Naples 6
Quzhou 6
Scottsdale 6
Abidjan 5
Baotou 5
Chaoyang 5
Edinburgh 5
Fairfield 5
Mestre 5
Pune 5
Rio Saliceto 5
Carpineti 4
Genova 4
Horia 4
Jakarta 4
Jinhua 4
Leawood 4
London 4
Totale 11.620
Salva come PNG Salva come JPEG
Nome #
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 195
Cap. 6. Differenziamento reale e differenziamento temporaneo. 126
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 113
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 109
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 107
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 97
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 94
Metabolic profiling of Candida albicans 91
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 90
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 90
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 90
Antifungal peptides within the antibodies 88
Screening of thiosemicarbazones as antimycotic drugs 87
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 85
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 84
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 83
Antibody-mediated protective immunity in fungal infections 82
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 81
Antibody peptide based antifungal immunotherapy 81
Antibodies as a source of anti-infective peptides: an update 81
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 81
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 79
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 78
Fungicidal activity of peptides encoded by immunoglobulin genes 78
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 78
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 77
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 76
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 75
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 75
Anti-septic shock recombinant vaccine. 75
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 75
A synthetic peptide as a novel anticryptococcal agent 74
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 74
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 73
Agenti virali di gastroenterite. 73
Antibodies as Crypts of Antiinfective and Antitumor Peptides 73
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 73
Natural and synthetic peptides with antifungal activity 73
Applicazioni della Biologia Molecolare in Micologia. 72
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 72
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 72
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 72
Peptides from the inside of the antibodies are active against infectious agents and tumours 72
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 71
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 71
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 71
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 70
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 70
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 70
Antibiobodies: antibiotic internal image antibodies 69
Wickerhamomyces yeast killer toxins’ medical applications 69
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 68
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 68
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 68
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 66
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 66
Antireceptor yeast killer toxin-like antibiobodies 66
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 66
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 66
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 66
Antifungal activity of the C-terminal peptide from human serum albumin 66
Metabolic profile of Candida albicans 66
Anticorpi immagini interne di tossine killer 66
Spettro d'azione universale di mimotopi killer antifungini 65
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 65
Antibiobodies: antibiotic-like antiidiotypic antibodies. 65
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 64
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 64
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 64
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 63
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 63
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 63
Any antibody fragment might exert antifungal activity 63
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 63
L'automazione integrata nel Laboratorio di Batteriologia. 63
Indagini batteriologiche e virologiche su campioni di feci in pazienti affetti da gastroenterite acuta osservati presso gli Ospedali Riuniti di Parma. 62
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 62
Attività protettiva di anticorpi killer anti-idiotipo nell’aspergillosi polmonare invasiva in un modello murino di trapianto di midollo osseo allogenico privo di linfociti T. 62
Mode of action of a killer peptide against Toxoplasma gondii 62
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 62
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 61
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 61
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 61
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 61
Immunizzazione neonatale nei confronti dell'infezione da streptococco di gruppo B mediante vaccini antiidiotipici ricombinanti. 60
Innate antimicrobial and antiviral activities of antibody peptides 60
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 60
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 60
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 60
Protective antifungal yeast killer toxin-like antibodies 59
Les récepteurs des toxines killer de levure 59
Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods. 59
Capitolo 6. Genetica dei microrganismi 59
A transphyletic anti-infectious control strategy based on the killer phenomenon. 59
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 59
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 58
Sintesi di RNA complementari e virali in cellule infettate con il virus dell'influenza. 58
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 58
Restriction of Influenza virus multiplication induced by PK peptide treatment 58
Automazione dell’antibiogramma diretto sulle urine. 58
Totale 7.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.885 0 0 0 116 463 495 572 119 373 317 105 325
2020/20212.308 10 323 310 25 337 27 325 21 480 46 352 52
2021/20221.638 27 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20251.021 48 415 404 154 0 0 0 0 0 0 0 0
Totale 18.596